Venus Remedies Share Price
VENUSREM
Live Venus Remedies Share Price Chart
Venus Remedies Performance
Days Range
| Previous Close | ₹1,522.60 |
|---|---|
| Open | ₹1,494 |
| Volume | 98,755 |
| Day's Range | ₹1,446.90 - ₹1,565.00 |
|---|---|
| 52W Range | ₹424.00 - ₹2,044.30 |
| Market Cap | ₹2,031.58 Cr |
Venus Remedies Fundamentals
| ROCE(TTM) | 19.85 |
|---|---|
| P/E Ratio (TTM) | 17.49 |
| P/B Ratio | 3.06 |
| Industry P/E | 37.01 |
| Debt to Equity | 0.02 |
| ROE | 15.49 |
| EPS (TTM) | 86.92 |
| Dividend Yield | 0.66 |
| Book Value | 496.56 |
| Face Value | 10 |
| ROCE(TTM) | 19.85 |
|---|---|
| P/E Ratio (TTM) | 17.49 |
| P/B Ratio | 3.06 |
| Industry P/E | 37.01 |
| Debt to Equity | 0.02 |
| ROE | 15.49 |
|---|---|
| EPS (TTM) | 86.92 |
| Dividend Yield | 0.66 |
| Book Value | 496.56 |
| Face Value | 10 |
Venus Remedies Financials
| Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|
| Net Sales | 192.75 | 180.26 | 259.40 | 178.86 |
| Expenses | 167.96 | 149.30 | 202.73 | 151.44 |
| Profit before tax | 26.49 | 33.47 | 61.61 | 30.04 |
| Operating Profit | 20.13 | 25.58 | 47.50 | 22.97 |
| Net Profit | 20.13 | 25.58 | 47.50 | 22.97 |
| EPS in Rs | 15.06 | 19.14 | 35.53 | 17.18 |
Venus Remedies Shareholding Pattern
Promoters
41.76%
Retail And Others
54.43%
Foreign Institutional Investors
2.92%
Domestic Institutional Investors
0.89%
About Venus Remedies
Incorporated in 1989 as Venus Glucose Pvt Ltd the company was converted into public limited company in 1994 and then changed into Venus Remedies Limited. The company was promoted and managed by Chaudhary & Family. The company was mainly engaged in I/V fluids & injectables,ceftazidime,amlodipine,gliclazide,lisinopril.
The production was started in 1991 with Intravenous/Intramuscular injectible forms at Panchkula district at Haryana. In 1994 it introduced Eye/Ear/Nose drops. The company received the certificate as 'WHO-GMP' as specified by WHO,Geneva. Venus Remedies set up a Cephalosporin project with an Australian collaboration with US-FDA standards at a cost of Rs.4.5 crores. The company is manufacturing injections for the top companies like Panacea Biotech ltd,Morepan Labortories ltd etc.
In 2001 with the help of Product Development Committee(PDC) Venus Remedies had introduced 13 new products in the Animal Health Division namely Megox-3000,Paroxin-3000,Pisa-3000,Mical,Ronid,Dexolyte and Detox.
Parent Organisation
Indian Private
Managing Director
Pawan Chaudhary
Founded
1989
NSE Symbol
VENUSREM
Top Mutual Funds Invested in Venus Remedies Share
Data is not available currently. Please check back later.
Peer Comparison
| Stocks | LTP (₹) | Market Cap (cr) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 1,942.0 -2.40 (-0.12%) | ₹4,68,530.14 | 1,548.0 - 2,046.9 |
| Divis Laboratories Ltd | 8,560.0 260.00 (3.13%) | ₹2,19,675.25 | 5,636.5 - 8,585.0 |
| Torrent Pharmaceuticals Ltd | 4,883.0 -41.00 (-0.83%) | ₹1,86,969.82 | 3,480.6 - 5,250.0 |
| Cipla Ltd | 1,463.0 -4.70 (-0.32%) | ₹1,17,945.42 | 1,165.7 - 1,673.0 |
| Zydus Lifesciences Ltd | 1,194.3 75.30 (6.73%) | ₹1,11,790.25 | 835.5 - 1,205.0 |
| Lupin Ltd | 2,278.9 -21.10 (-0.92%) | ₹1,04,020.40 | 1,875.0 - 2,529.5 |
Popular Stocks
Venus Remedies Ltd FAQs
Can I buy Venus Remedies Ltd (VENUSREM) from Angel One?
Yes, You can buy Venus Remedies Ltd (VENUSREM) shares by opening a Demat account with Angel One.
How do I buy Venus Remedies Ltd (VENUSREM) from Angel One?
Venus Remedies Ltd (VENUSREM) share can be bought through the following modes:
1. Direct investment: You can buy Venus Remedies Ltd (VENUSREM) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Venus Remedies Ltd (VENUSREM) shares.
1. Direct investment: You can buy Venus Remedies Ltd (VENUSREM) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Venus Remedies Ltd (VENUSREM) shares.
